SCHEMBL6940591

SCHEMBL6940591

CC(=O)Nc1ccc2ccn(CCC[C@@H](O[Si](C)(C)C(C)(C)C)n3cnc(C(N)=O)c3)c2c1

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADA P00813 19/20 0.68
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6938297 0.90 ADA (0.71) ADA
SCHEMBL6933243 0.88 ADA (0.53) ADAMCL1
SCHEMBL6942307 0.88 ADA (0.53) ADAMCL1
SCHEMBL6939458 0.88 ADA (0.70) ADA
SCHEMBL6942389 0.88 ADA (0.70) ADA
SCHEMBL6935388 0.87 ADA (0.72) ADA
SCHEMBL6938255 0.87 ADA (0.60) ADA
SCHEMBL6936393 0.87 ADA (0.69) ADA
SCHEMBL6936168 0.87 ADA (0.73) ADA
SCHEMBL7848242 0.87 ADA (0.72) ADA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed
EP-1161429-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP disclosed
WO-2000055155-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-09-21 WO disclosed